Common to both acute and chronic disease are disturbances in energy homeostasis, which are evidenced by quantitative and qualitative changes in dietary intake and increased energy expenditure. Negative energy balance results in loss of fat and lean tissue. The management of patients with metabolically-active disease appears to be simple; it would involve the provision of sufficient energy to promote tissue accretion. However, two fundamental issues serve to prevent nutritional demands in disease being met. The determination of appropriate energy requirements relies on predictive formulae. While equations have been developed for critically-ill populations, accurate energy prescribing in the acute setting is uncommon. Only 25-32 % of the patients have energy intakes within 10 % of their requirements. Clearly, the variation in energy expenditure has led to difficulties in accurately defining the energy needs of the individual. Second, the acute inflammatory response initiated by the host can have profound effects on ingestive behaviour, but this area is poorly understood by practising clinicians. For example, nutritional targets have been set for specific disease states, i.e. pancreatitis 105-147 kJ (25-35 kcal)/kg; chronic liver disease 147-168 kJ (35-40 kcal)/kg, but given the alterations in gut physiology that accompany the acute-phase response, targets are unlikely to be met. In cancer cachexia attenuation of the inflammatory response using eicosapentaenoic acid results in improved nutritional intake and status. This strategy poses an attractive proposition in the quest to define nutritional support as a clinically-effective treatment modality in other disorders.
In both acute and chronic disease there are disturbances in energy homeostasis in which the consequences of the inflammatory response may affect both sides of the energy balance equation. For example, following trauma or major surgery, tissue injury and the resultant systemic inflammation may induce hypermetabolism. This outcome is also apparent in pathologies such as acute and chronic pancreatitis, inflammatory bowel disease and cancer. In such cases energy demands may also be altered, as evidenced by quantitative and qualitative changes (Davidson et al. 1999) in dietary intake in addition to increased energy expenditure (Schols, 2001) .
It has been suggested that the presence of pathologies that induce a metabolic response contributes not only to diseaserelated undernutrition but may compound co-morbidity driven by poor immune function. The resolution of these anomalies of energy metabolism would seem simplistic, in that the provision of nutritional support (oral enteral or parenteral) sufficient to meet requirements would serve to arrest any energy drain. However, it is clear that the provision of nutrients per se will not replete losses of lean body mass or endogenous fat stores. The reason for this situation lies in the pathophysiological events that dictate the inflammatory response.
Returning to the energy balance equation, and more precisely energy input, an appreciation of the central role that inflammation has in relation to ingestive behaviour is not widely acknowledged. Recognition of the mechanisms that regulate or bring about dysfunction of such feeding behaviour in both acute and chronic disease may permit the development of strategies that would modulate the impact of the inflammatory response on dietary intake.
The inflammatory response initiated by the host can have profound effects on neurophysiological mechanisms responsible for ingestive behaviour (Konsman & Dantzer, 2001 ). This process is primarily driven by the production of 
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